Latest Medicare Advantage News

Humana delivered a better-than-expected third quarter on insurance claims performance, lifting its 2026 adjusted EPS guidance despite reporting an adjusted loss for the period. The company also flagged stronger CenterWell growth and a lower-cost BlackRock joint venture as part of its path towards a 3% pretax margin by 2028.

Pacific Edge has secured final Medicare coverage for Cxbladder Triage and Triage Plus in intermediate-risk microhematuria, with the policy due to take effect on 20 December. The decision gives the company a clearer reimbursement pathway, but revenue gains still depend on adoption and testing volumes.

Lumos Diagnostics has achieved a major milestone by securing 100% Medicare reimbursement recognition for its FebriDx test across all seven US Medicare Administrative Contractors, paving the way for broader adoption in the American healthcare system.

Pacific Edge faces a significant Medicare reimbursement setback as Novitas finalizes a non-coverage decision for its Cxbladder tests, prompting the company to activate legal challenges and operational restructuring.